Short answer
Chemed Corp (CHE) filed an 8-K current report with the SEC on July 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results announced for quarter ended June 30, 2026.
Chemed Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results announced for quarter ended June 30, 2026
- Investor-relevant financial details contained in furnished Exhibit 99 press release
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $673.3M, up 8.8%; GAAP EPS $5.13, up 43.7%, adjusted EPS $6.06, up 41.9%
- VITAS drove upside: revenue $443.3M, up 11.9%; adjusted EBITDA $80.6M, up 20.6%, margin 18.2%
- Medicare Cap drag sharply reduced: $500K accrued versus $16.4M prior year, supporting VITAS profitability
- Roto-Rooter growth modest: revenue $229.9M, up 3.3%; adjusted EBITDA margin declined 77 basis points to 21.1%
- Full-year adjusted EPS guidance raised to $25.00-$25.75 from $24.00-$24.75, midpoint implying 17.8% growth
- Capital returns remain aggressive: $89.8M spent repurchasing 210,000 shares, with $139.8M authorization remaining
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Chemed Corp 8-K filings
Get the next CHE 8-K as it lands
Follow CHE for push alerts, or ask the research agent what this filing means.